Cardiologist
MBBS, MD (AIIMS Delhi)
Cancer Immunotherapy Physician
Dr. Vikesh Shah’s journey began with academic excellence, but his purpose was clear: to bring meaningful change in cancer care.
His grounded personality and visionary mindset reflect in every decision, every dose, and every life he touches.
Long before it gained popularity, he believed in the immune system’s potential to fight cancer. This belief became his lifelong pursuit.
ImmunoHope isn’t just a clinic — it’s a vision. Built with patient-first values and driven by research, it gives life to personalized healing.
Coming to ImmunoHope is not just about treatment—it’s about recovery and rejuvenation. Patients can explore India’s rich heritage, natural beauty, and wellness traditions during their stay. Many combine their medical journey with restorative practices like yoga, meditation, and Ayurveda for a holistic healing experience.
- MBBS : Dr. NTR University of Health Sciences, Andhra Pradesh
- MD : AIIMS, New Delhi
- Dr. Vikesh Shah has a strong foundation in both conventional oncology and advanced immunotherapy.
Dr. Shah has authored multiple national and international research papers on dendritic cell immunotherapy and rare cancer types. His clinical work reflects a strong focus on translational medicine and patient-centered innovations in cancer treatment.
Key Publications Include:
- Dendritic Cell-Based Immunotherapy in Advanced Solid Tumors – European Journal of Molecular & Clinical Medicine
- Squamous Cell Carcinoma in Young Adults: A Meta-analysis – EJMC
- Nutrition and Care in Head & Neck Cancer – JAMDSR
- Awarded by Dr. APJ Abdul Kalam, former President of India
- MD degree conferred by Dr. JP Nadda, former Union Health Minister
- Pioneered outreach and awareness camps on immunotherapy across India
- Treated numerous patients successfully in advanced cancer stages with minimal side effects
Every action we take is rooted in empathy, innovation, and integrity — ensuring each patient feels seen, heard, and healed.
To empower every cancer patient with hope and healing through personalized immunotherapy rooted in science and compassion.
To make immunotherapy accessible, effective, and patient-centered by combining research, clinical expertise, and heartfelt care.
Driven by empathy, ethics, innovation, and a relentless commitment to improving lives through cutting-edge, human-first cancer care.